1. Latest News
  2. Submit Press Release
Insight Pharma Reports Logo

Insight Pharma Reports Announces Biomarkers in Parkinson’s Disease Report

Understand the market growth of biomarkers, advantages, disadvantages, and validation techniques

PRLog - Aug. 25, 2014 - NEEDHAM, Mass. -- Insight Pharma Reports, a scientific report leader for over 15 years, released a new report on Biomarkers in Parkinson’s Disease. Biomarkers in Parkinson’s Disease is focused on the biomarker identification and development in patients with Parkinson’s Disease. This report focuses on the Parkinson’s Disease space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing the use of biomarkers for Parkinson’s Disease, Biomarkers in Parkinson’s Disease captures market growth of biomarkers, advantages, disadvantages, and validation techniques.

Experts interviewed in this report include:

· Dr. Andrew West, Associate Professor of Neurology and Neurobiology and Co-Director, Center for Neurodegeneration and Experimental Therapeutics

· Dr. Xuemei Huang, Professor and Vice Chair, Department of Neurology; Professor of Neurosurgery, Radiology, Pharmacology, and Kinesiology Director; Hershey Brain Analysis Research Laboratory for Neurodegenerative Disorders, Penn State University-Milton, S. Hershey Medical Center Department of Neurology

· Dr. Andreas Jeromin, CSO and President of Atlantic Biomarkers

Also available in this report is extensive survey data exclusively conducted for this report. Illustrated by 30 figures captured in an in-depth analysis, this section features insight into targets under investigation, challenges, advantages, and desired features of future diagnostic applications.

Insight Pharma Reports also engineered a table of clinical trial information and pipeline data from multiple databases related to Parkinson’s Disease. This table features companies, targets, clinical phases, and brief target/product descriptions.

For more information and to purchase this Insight Pharma Report, visit: http://www.insightpharmareports.com/biomarkers-in-parkins...

or contact Kerri Kelley at kkelley@healthtech.com or 781-972-1347.

About Insight Pharma Reports

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute.  http://www.InsightPharmaReports.com

Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/affiliatedreports/

Kerri Kelley

--- End ---

Click to Share

Contact Email:
Source:Insight Pharma Reports
Location:Needham - Massachusetts - United States
Industry:Biotech, Medical
Tags:Insight Pharma Reports, pharma reports, parkinson s, biomarkers, parkinson s disease
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

Like PRLog?
Click to Share